danazol
Generic: DANAZOL·Brand: DANAZOL, DANOCRINE
danazol: developed by 1 company · 1 FDA decision.
danazol evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect danazol to LCI; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could danazol → LCI affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Development Pipeline (1)
| Company | Phase |
|---|---|
| LANNETT CO INC (LCI) | Approved |
FDA Decisions1 records
ApprovalINDICATIONS AND USAGE Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females.(LCI)FDA ↗
ANDA078214OralCapsule
Frequently asked questions
Who is developing danazol?
danazol is being developed by LANNETT CO INC.
What is danazol's latest FDA decision?
The most recent tracked FDA decision for danazol is Approval for INDICATIONS AND USAGE Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females., dated April 19, 2007.